Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Montai Therapeutics

News headline image
Montai Therapeutics Doses First Participants in Phase 1 Clinical Trial of MTAI-1025, a Novel Oral NRF2 Agonist for Ulcerative Colitis
From Montai Therapeutics
Via Business Wire
News headline image
Montai Therapeutics Presents Preclinical Data on NRF2 Agonist in Ulcerative Colitis at ACAAI Annual Meeting
From Montai Therapeutics
Via Business Wire
News headline image
Montai Therapeutics Appoints Hans Hull as Chief Operations Officer
From Montai Therapeutics
Via Business Wire
News headline image
Montai Therapeutics Appoints Allison Bogosian, JD, as Chief People and Administrative Officer
From Montai Therapeutics
Via Business Wire
News headline image
Montai Therapeutics Appoints Renowned Chemical Innovator Larry Hamann to Company’s Board of Directors, Convenes Multidisciplinary Scientific Advisory Board to Inform Strategic Momentum
From Montai Therapeutics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.